Video/Audio
Video/Audio
2019
2018
-
April 9-12, 2018
The Great Oncolytic Debate: For the success of oncolytic viruses – single cycle cures or repeat treatments?
Oxford, UK
Stephen J. Russell, M.D., Ph.D., Vyriad CEO, has been invited to Chair, Innate and collateral adaptive tumor immunity. Dr. Russell will also participate in Steve Russell (Once should be enough!) vs. Alan Melcher (Repeat dosing is crucial!)
-
June 26, 2016
This Week in Virology
TWIV
Video podcast with featured guest Stephen Russell, MD, PhD, CEO & President of Vyriad
-
February 27, 2015
Star Tribune
“VICE Special Report: Killing Cancer”
-
October 24, 2014
Mayo Clinic
Serendipity: How a Cancer-Fighting Measles Virus Brought Together Patient and Benefactors